7.1.37.3DALearning Outcome
End-of-life decision-making within the team and with patient relatives (e.g. withholding/withdrawing therapy, organ donation) Knowledge GENERAL ICU ISSUES
lines 778–789id: LO_7.1.37_3_DA
26 items
- 7.1.37_3.1DAVentilation strategies and non-ventilator therapies to optimise oxygenation and ventilation and minimise lung injury
- 7.1.37_3.2DAInitiation of non-invasive ventilation (NIV) and management of patients receiving NIV in the intensive care setting
- 7.1.37_3.3DARoles and selection of different modes of ventilation, including but not limited to continuous mandatory ventilation, volume control modes, pressure control modes, synchronised intermittent mandatory ventilation, pressure support, *inverse ratio ventilation, continuous positive airway pressure (CPAP), bilevel/airway pressure release ventilation and high-frequency oscillation
- 7.1.37_3.4DAComplications of ventilation and the strategies to minimise ventilator-induced lung injury, including the ventilation of acute respiratory distress syndrome (ARDS) patients
- 7.1.37_3.5DAHaemodynamic effects of positive pressure ventilation (heart-lung interactions)
- 7.1.37_3.6DAPathophysiology of and approach to the management of patient-ventilator dyssynchrony
- 7.1.37_3.7DAInterpret and use blood gas analysis to guide respiratory support
- 7.1.37_3.8DAVentilator graphics (pressure, flow, volume, loops)
- 7.1.37_3.9DADecisions to wean ventilation, strategies for weaning patients from ventilator support and assessment of success
- 7.1.37_3.10DADeliberate indications for the use of extracorporeal membrane oxygenation (ECMO) in respiratory failure and the principles of its delivery
- 7.1.37_3.11DAAntimicrobial classification according to the mode of action and spectrum of activity
- 7.1.37_3.12DAIndications, mechanisms of action, adverse effects and resistance
- 7.1.37_3.13DAAdverse effects of antimicrobial agents in the critically ill patient
- 7.1.37_3.14DAAntimicrobial stewardship, empirical and directed antimicrobial therapy
- 7.1.37_3.15DAImplications of organ dysfunction/failure for antibiotic prescribing and efficacy
- 7.1.37_3.16DAProvision and assessment of analgesia and sedation for critically ill patients
- 7.1.37_3.17DASedation procedures in the ICU
- 7.1.37_3.18DAEffect of critical illness on the pharmacokinetics and pharmacodynamics of sedative and analgesic agents
- 7.1.37_3.19DAImpact of organ dysfunction and critical illness on the efficacy of analgesia and sedation
- 7.1.37_3.20DAWeaning protocols of sedative and analgesic agents and strategies to prevent withdrawal phenomena
- 7.1.37_3.21DAIndications for and contraindications to the use of neuromuscular blockade and pharmacology of neuromuscular blocking drugs
- 7.1.37_3.22DAComplications of the use of neuromuscular blockade
- 7.1.37_3.23DAMonitoring for muscle relaxation estimation of nutritional requirements
- 7.1.37_3.24DAHead injury and Glasgow Coma Scale (GCS)
- 7.1.37_3.25DACervical spine injuries
- 7.1.37_3.26DASpinal shock